UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.51+0.94 (+2.26%)
At close: 04:00PM EDT
43.00 +0.49 (+1.15%)
After hours: 07:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
60,270
51,844
24
18
0
Operating expenses
Research development
262,391
387,087
103,179
54,619
33,873
Selling general and administrative
66,196
57,222
29,605
20,553
11,868
Total operating expenses
328,587
444,309
132,784
75,172
45,741
Operating income or loss
-268,317
-392,465
-132,760
-75,154
-45,741
Interest expense
-
-
-
187
-
Total other income/expenses net
29,369
21,836
-63,400
-5,471
-71,289
Income before tax
-238,292
-370,638
-194,592
-78,326
-116,738
Income from continuing operations
-238,292
-370,638
-194,592
-78,326
-116,738
Net income
-238,292
-370,638
-194,592
-78,326
-115,257
Net income available to common shareholders
-238,292
-370,638
-195,869
-91,040
-115,257
Basic EPS
-
-5.77
-4.19
-2.01
-8.90
Diluted EPS
-
-5.77
-4.19
-2.01
-8.90
Basic average shares
-
64,228
46,733
45,325
12,953
Diluted average shares
-
64,228
46,733
45,325
12,953
EBITDA
-
-385,014
-128,025
-74,636
-45,091